Shahar Azar

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Natural microbiota confer life-long protection against obesity via an early-life, immune-mediated effect on brown adipocytes.

Natural microbiota confer life-long protection against obesity via an early-life, immune-mediated effect on brown adipocytes.

Journal: Gut microbes
Published: August 24, 2026

Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration.

Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration.

Journal: British journal of pharmacology
Published: August 18, 2025

The role of immune responses and microbiota in adipose tissue homeostasis.

The role of immune responses and microbiota in adipose tissue homeostasis.

Journal: The Journal of physiology
Published: June 30, 2025

Naturalized immune responses are stable over years in a colony of laboratory mice with wild-derived microbiota.

Naturalized immune responses are stable over years in a colony of laboratory mice with wild-derived microbiota.

Journal: Immunity
Published: September 14, 2024

Characterization of metabolic alterations in the lean metabolically unhealthy alpha defensin transgenic mice.

Characterization of metabolic alterations in the lean metabolically unhealthy alpha defensin transgenic mice.

Journal: iScience
Published: May 19, 2023

Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults.

Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults.

Journal: Life (Basel, Switzerland)
Published: August 07, 2022

Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes.

Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 12, 2022

The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity.

The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity.

Journal: International journal of molecular sciences
Published: April 29, 2022

Sleeve Gastrectomy Suppresses Hepatic Glucose Production and Increases Hepatic Insulin Clearance Independent of Weight Loss.

Sleeve Gastrectomy Suppresses Hepatic Glucose Production and Increases Hepatic Insulin Clearance Independent of Weight Loss.

Journal: Diabetes
Published: March 24, 2021

Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption.

Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption.

Journal: Frontiers in endocrinology
Published: March 24, 2021

CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance.

CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance.

Journal: eLife
Published: July 06, 2020

Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.

Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.

Journal: Molecular metabolism
Published: May 19, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026